C-reactive protein. Structural biology, gene expression, and host defense function

Immunologic Research

Volumn 16, Issue 2, 1997, Pages 127-136

  Szalai, Alex J ^a   Agrawal, Alok ^a   Greenhough, Trevor J ^b   Volanakis, John E ^a,c  

^a The University of Alabama at Birmingham   (United States)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

C reactive protein; Crystal structure; Expression; Host defense

Indexed keywords

C REACTIVE PROTEIN;

BINDING SITE; CRYSTAL STRUCTURE; GENE EXPRESSION; HOST RESISTANCE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; STREPTOCOCCUS PNEUMONIAE; TRANSGENIC MOUSE; X RAY CRYSTALLOGRAPHY;

EID: 0030794248     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786357     Document Type: Review

References (34)

1. Shrive AK, Cheetham GMT, Holden D, Myles DAA, Turnell WG, Volanakis JE, Pepys MB, Bloomer AC, Greenhough TJ: Three dimensional structure of human C-reactive protein. Nature Struct Biol 1996;3:346-354.
2. Emsley J, White HE, O'Hara BP, Oliva G, Srinivasan N, Tickle IJ, Blundell TL, Pepys MB, Wood SP: Structure of pentameric human serum amyloid P component. Nature 1994;367:338-345.
3. Einspahr H, Parks EH, Suguna K, Subramanian E, Suddath FL: The crystal structure of pea lectin at 3.0-Å resolution. J Biol Chem 1986;261:16,518-16,527.
4. Reeke GN Jr, Becker JW, Edelman GM: The covalent and three-dimensional structure of concanavalin A. IV. Atomic coordinates, hydrogen bonding, and quaternary structure. J Biol Chem 1975; 250:1525-1547.
5. Srinivasan N, White HE, Emsley J, Wood SP, Pepys MB, Blundell TL: Comparative analyses of pentraxins: implications for protomer assembly and ligand binding. Structure 1994;2:1017-1027.
6. Abernathy TJ, Avery OT: The occurrence during acute infections of a protein not normally present in the blood. I. Distribution of the reactive protein in patient's sera and the effect of calcium on the flocculation reaction with C-polysaccharide of pneumococcus. J Exp Med 1941;73:173-182.
7. Volanakis JE, Kaplan MH: Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 1971;136:612-614.
8. Baldo BA, Fletcher TC, Pepys J: Isolation of a peptido-polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C-reactive protein and a mouse antiphosphorylcholine myeloma serum. Immunology 1977;32:831-842.
9. Löfström G: Comparison between the reactions of acute phase serum with pneumococcus C-polysaccharide and with pneumococcus type 27. Br J Exp Pathol 1944;25:21-26.
10. Kaplan MH, Volanakis JE: Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphinogomyelin. J Immunol 1974;112:2135-2147.
11. Agrawal A, Kilpatrick JM, Volanakis JE: Structure and function of human C-reactive protein; in Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. Mackiewicz A, Kushner I, and Baumann H (eds), CRC Press, Ann Arbor MI, 1993, pp 79-92.
12. Volanakis JE, Xu Y, Macon KJ: Human C-reactive protein and host defense; in Marchalonis JJ, Reinisch CL (eds): Defense Molecules. New York, Alan R Liss, 1990, 161-175.
13. Agrawal A, Xu Y, Ansardi D, Macon KJ, Volanakis JE: Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis. J Biol Chem 1992;267:25,352-25,358.
14. 67. J Immunol 1997;158:345-350.
15. Wong GG, Witek JS, Temple PA, Wilkens KM, Leary AC, Luxenberg DP, Jones SS, Brown EL, Kayi RM, Orr EC, Shoemaker C, Golde DW, Kaufman RJ, Hewick RM, Wang EA, Clark SC. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985;228:810-815.
16. Kilpatrick JM, Kearney JF, Volanakis JE: Demonstration of calcium-induced conformational change(s) in C-reactive protein by using monoclonal antibodies. Mol Immunol 1982;19: 1159-1165.
17. Volanakis JE, Kaplan MH: Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes. Requirement for human Clq. J Immunol 1974;113:9-17.
18. Cooper NR: The classical complement pathway. Activation and regulation of the first complement component. Adv Immunol 1985; 37:151-216.
19. Duncan AR, Winter G: The binding site for Clq on IgG. Nature 1988; 332:738-740.
20. Tao MH, Smith RIF, Morrison SL: Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med 1993;178:661-667.
21. Agrawal A., Volanakis JE: Probing the Clq-binding site on human C-reactive protein by site-directed mutagenesis. J Immunol 1994; 152:5404-5410.
22. Roux KH, Kilpatrick JM, Volanakis JE, Kearney JF: Localization of the phosphocholine-binding sites on C-reactive protein by immunoelectron microscopy. J Immunol 1983;131:2411-2415.
23. Anderson JK, Stroud RM, Volanakis JE: Studies on the binding specificity of human C-reactive protein for phosphorylcholine. Fed Proc 1978;37:1495.
24. Pepys MB, Baltz ML, Gomer K, Davies AJS, Doenhoff M: Serum amyloid P component is an acute-phase reactant in the mouse. Nature 1979;278:259-261.
25. Ciliberto G, Arcone R, Wagner EF, Rüther U: Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J 1987;6:4017-4022.
26. Murphy C, Beckers J, Rüther U: Regulation of the human C-reactive protein gene in transgenic mice. J Biol Chem 1995;270:704-708.
27. Szalai AJ, Briles DE, Volanakis JE: Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 1995; 155:2557-2563.
28. Szalai AJ, Briles DE, Volanakis JE: The role of complement in C-reactive protein mediated protection of mice from Streptococcus pneumoniae. Infec Immunol 1996; 64:4850-4853.
29. Volanakis JE: Complement activation by C-reactive protein complexes. Ann NY Acad Sci 1982; 389:235-250.
30. Horowitz J, Volanakis JE, Briles DE: Blood clearance of Streptococcus pneumoniae by C-reactive protein. J Immunol 1987;138: 2598-2603.
31. Ganrot PO, Kindmark CO: C-reactive protein - a phagocytosis promoting factor. Scand J Clin Lab Invest 1969;24:215-219.
32. Nakayama S, Gewurz H, Holzer T, DuClos TW, Mold C: The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection. Clin Exp Immunol 1983; 54:319-326.
33. Hosea SW, Brown EJ, Frank MM: The critical role of complement in experimental pneumococcal sepsis. J Infect Dis 1980;142:903-909.
34. Marnell LL, Mold C, Volzer MA, Burlingame RW, DuClos TW: C-reactive protein binds to FcγR1 in transfected COS cells. J Immunol 1995;155:2185-2193.